The Fund aims to achieve above average capital growth.
Name | % Net Assets |
---|---|
Roche Holding AG | 4.6% |
EFG Eurobank Ergasias S.A. | 3.9% |
Total S.A. | 3.3% |
ASML Holding N.V. | 3.0% |
AXA S.A. | 3.0% |
UBS Ag | 2.9% |
TrygVesta A/SV. | 2.8% |
Carrefour S.A. | 2.7% |
Nexans | 2.6% |
Banco Bilbao Vizcaya Argentaria S.A. | 2.5% |
Key | % Net Assets |
---|---|
Roche Holding AG | 4.6% |
EFG Eurobank Ergasias S.A. | 3.9% |
Total S.A. | 3.3% |
ASML Holding N.V. | 3.0% |
Other | 85.2% |
Date | 21-Nov-2024 |
---|---|
NAV | 519.25p |
Currency | GBP |
Change | 0.000p |
% | n/a |
YTD change | 4.65p |
YTD % | 0.90% |
Fund Inception | 31/10/1986 |
---|---|
Fund Manager | Phil Cliff |
TER | 1.05 (30-Mar-2012) |
Minimum Investment | |
---|---|
Initial | £500000 |
Additional | n/a |
Savings | n/a |
Charges | |
---|---|
Initial | n/a |
Annual Mang't | 1.00% |
Exit | n/a |
Name | % |
---|---|
Standard deviation | 0.02 |
Sharpe ratio | 0.09 |
You are here: research